Table 5

Unadjusted rates of outcomes

Patient–provider interaction analyses (n=2106)No app
% (95% CI)
(n=1794)
App only
% (95% CI) (n=150)
P value*App+discussion
% (95% CI) (n=162)
P value*
SDM†55 (52 to 57)48 (40 to 56)0.14364 (56 to 72)0.023
Physician disease tracking†59 (57 to 62)52 (44 to 60)0.09471 (63 to 78)0.005
Disease management analyses (n=1695)No app
% (95% CI) (n=1383)
App only
% (95% CI) (n=157)
P value*App+discussion
% (95% CI) (n=155)
P value*
Low disease activity at last visit63 (60 to 66)68 (60 to 76)0.20269 (61 to 76)0.168
Improved disease activity49 (46 to 52)51 (42 to 59)0.81452 (43 to 61)0.631
Treatment intensification18 (16 to 20)22 (15 to 29)0.34715 (10 to 22)0.464
  • 2 test of difference compared with no app use group.

  • †Maximum rating of physician effort in SDM or physician disease tracking (see Patients and methods section, Evaluation approach section and figure 1 for more details on the survey questions used).

  • SDM, shared decision making.